Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
---|---|
Information provided by: | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
ClinicalTrials.gov Identifier: | NCT00027053 |
This study is a randomized, double-blind clinical trial comparing trazodone (Desyrel) and placebo among sleep-disturbed, alcohol-dependent individuals shortly after discharge from an inpatient detoxification program. Subjects will undergo a baseline assessment and random assignment to trazodone or identical placebo for 12 weeks. All persons completing the alcohol detoxification at Stanley Street Treatment and Resources (SSTAR) will be screened. (SSTAR of Rhode Island provides detoxification services to non/underinsured persons of Rhode Island.)
Condition | Intervention | Phase |
---|---|---|
Alcoholism |
Drug: trazodone (Desyrel) |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Efficacy Study |
Official Title: | Trazodone for Sleep Disturbance - Early Alcohol Recovery |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | NIAAAFRI13243, NIH grant R01 AA013243 |
Study First Received: | November 19, 2001 |
Last Updated: | March 3, 2006 |
ClinicalTrials.gov Identifier: | NCT00027053 |
Health Authority: | United States: Federal Government |
alcoholism alcohol dependence trazadone sleep |
Signs and Symptoms Mental Disorders Trazodone Alcoholism Substance-Related Disorders Neurologic Manifestations |
Disorders of Environmental Origin Dyssomnias Sleep Disorders Alcohol-Related Disorders Serotonin Ethanol |
Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Tranquilizing Agents Molecular Mechanisms of Pharmacological Action Nervous System Diseases Physiological Effects of Drugs Psychotropic Drugs Central Nervous System Depressants |
Serotonin Uptake Inhibitors Pharmacologic Actions Serotonin Agents Therapeutic Uses Anti-Anxiety Agents Antidepressive Agents, Second-Generation Central Nervous System Agents Antidepressive Agents |